Measures of effect: Relative risks, odds ratios, risk difference, and 'number needed to treat'

Kidney International

Volumn 72, Issue 7, 2007, Pages 789-791

  Tripepi, G ^a   Jager, K J ^b   Dekker, F W ^b,c   Wanner, C ^d   Zoccali, C ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Epidemiology; Measures of effect; Number needed to treat; Odds ratio; Relative risk; Risk difference

Indexed keywords

PLACEBO; RAMIPRIL;

ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE PREDISPOSITION; EXPOSURE VARIABLE; HUMAN; INCIDENCE; KIDNEY FAILURE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOPHILIA; THROMBOSIS;

CONFIDENCE INTERVALS; HUMANS; ODDS RATIO; RISK;

EID: 34748833984     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002432     Document Type: Article

References (5)

1. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-153.
2. Parekh RS, Zhang L, Fivush BA et al. Incidence of atherosclerosis by race in the dialysis morbidity and mortality study: a sample of the US ESRD population. J Am Soc Nephrol 2005; 16: 1420-1426.
3. Jager KJ, Zoccali C, Kramar R et al. Measuring disease occurrence. Kidney Int. (in press).
4. Knoll GA, Wells PS, Young D et al. Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol 2005; 16: 1108-1114.
5. Szklo M, Nieto FJ. Epidemiology. Beyond the Basics. John and Bartlett publishers: Sudbury, MA, USA, 2004, pp 110-114.